比音勒芬(002832.SZ)半年度淨利潤預增45%-55%
格隆匯6月4日丨比音勒芬(002832.SZ)公佈,預計2021年半年度歸屬於上市公司股東的淨利潤23385.21萬元-24997.98萬元,同比增長45%-55%。業績變動原因如下:
1、報吿期內,公司繼續深耕主業,產品力、品牌力和營運能力得到了市場認可。產品研發持續創新,推出Outlast、黛奧蘭、故宮宮廷文化聯名等多個暢銷系列;品牌建設加大投入,開始在全國投放高鐵廣吿,並持續強化娛樂營銷,提升了品牌知名度和美譽度;營運方面深度運營VIP,實現個性化營銷,精細化管理。
2、企業數字化轉型加速,消費端與騰訊深度合作,智慧零售項目成效顯現。供給端提高協同效率。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.